The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Marine Natural Products and Related Compounds in Clinical and Advanced Preclinical Trials
Abstract
The marine environment has proven to be a very rich source of extremely potent compounds that have demonstrated significant activities in antitumor, antiinflammatory, analgesia, immunomodulation, allergy, and anti-viral assays. Although the case can and has been made that the nucleosides such as Ara-A and Ara-C are derived from knowledge gained from investigations of bioactive marine nucleosides, no drug directly from marine sources (whether isolated or by total synthesis) has yet made it to the commercial sector in any disease. However, as shown in this review, there are now significant numbers of very interesting molecules that have come from marine sources, or have been synthesized as a result of knowledge gained from a prototypical compound, that are either in or approaching Phase II/III clinical trials in cancer, analgesia, allergy, and cognitive diseases. A substantial number of other potential agents are following in their wake in preclinical trials in these and in other diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Progress in the Chemistry of Organic Natural Products 109
(2019) · Progress in the Chemistry of Organic Natural Products · doi:10.1007/978-3-030-12858-6 · Cited by 2,052
The influence of natural products upon drug discovery (Antiquity to late 1999)
Newman, D. J., Cragg, G. M., & Snader, K. M. (2000) · Natural Product Reports · doi:10.1039/a902202c · Cited by 1,293
Self-citationChemistry and Biology of the Tetrahydroisoquinoline Antitumor Antibiotics
Scott, J. D., & Williams, R. M. (2002) · Chemical Reviews · doi:10.1021/cr010212u · Cited by 1,149
Staats, P. S., Yearwood, T., Charapata, S. G., Presley, R. W., Wallace, M. S., Byas-Smith, M., Fisher, R., Bryce, D. A., Mangieri, E. A., Luther, R. R., et al. (2004) · JAMA · doi:10.1001/jama.291.1.63 · Cited by 654
Piel, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222481399 · Cited by 609
Halichondrins-antitumor polyether macrolides from a marine sponge
Hirata, Y., & Uemura, D. (1986) · Pure and Applied Chemistry · doi:10.1351/pac198658050701 · Cited by 519
Rinehart, K. L., Holt, T. G., Fregeau, N. L., Stroh, J. G., Keifer, P. A., Sun, F., Li, L. H., & Martin, D. G. (1990) · The Journal of Organic Chemistry · doi:10.1021/jo00302a007 · Cited by 492
Marine natural products and their potential applications as anti-infective agents
Donia, M., & Hamann, M. T. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00655-8 · Cited by 425
Total synthesis of halichondrin B and norhalichondrin B
Aicher, T. D., Buszek, K. R., Fang, F. G., Forsyth, C. J., Jung, S. H., Kishi, Y., Matelich, M. C., Scola, P. M., Spero, D. M., & Yoon, S. K. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00034a086 · Cited by 400
Natori, T., Morita, M., Akimoto, K., & Koezuka, Y. (1994) · Tetrahedron · doi:10.1016/s0040-4020(01)86991-x · Cited by 397
Cited by
Faulkner, D. J. (1990) · Natural Product Reports · doi:10.1039/np9900700269 · Cited by 4,866
Natural products: A continuing source of novel drug leads
Cragg, G. M., & Newman, D. J. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.02.008 · Cited by 2,906
Self-citationThe Biodiversity of the Mediterranean Sea: Estimates, Patterns, and Threats
Coll, M., Piroddi, C., Steenbeek, J., Kaschner, K., Ben Rais Lasram, F., Aguzzi, J., Ballesteros, E., Bianchi, C. N., Corbera, J., Dailianis, T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011842 · Cited by 2,155
Sponge-Associated Microorganisms: Evolution, Ecology, and Biotechnological Potential
Taylor, M. W., Radax, R., Steger, D., & Wagner, M. (2007) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00040-06 · Cited by 1,481
Impact of Natural Products on Developing New Anti-Cancer Agents
Cragg, G. M., Grothaus, P. G., & Newman, D. J. (2009) · Chemical Reviews · doi:10.1021/cr900019j · Cited by 1,302
Self-citationDrug development from marine natural products
Molinski, T. F., Dalisay, D. S., Lievens, S. L., & Saludes, J. P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2487 · Cited by 1,186
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Developing a new resource for drug discovery: marine actinomycete bacteria
Fenical, W., & Jensen, P. R. (2006) · Nature Chemical Biology · doi:10.1038/nchembio841 · Cited by 786
Natural products as leads to anticancer drugs
Gordaliza, M. (2007) · Clinical and Translational Oncology · doi:10.1007/s12094-007-0138-9 · Cited by 701
Drug discovery from natural sources
Chin, Y.-W., Balunas, M. J., Chai, H. B., & Kinghorn, A. D. (2006) · The AAPS Journal · doi:10.1007/bf02854894 · Cited by 662
Marine natural products as anticancer drugs
Simmons, T. L., Andrianasolo, E., McPhail, K., Flatt, P., & Gerwick, W. H. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.333.4.2 · Cited by 597
Metabolites from symbiotic bacteria
Piel, J. (2009) · Nat. Prod. Rep. · doi:10.1039/b703499g · Cited by 577
Martins, A., Vieira, H., Gaspar, H., & Santos, S. (2014) · Marine Drugs · doi:10.3390/md12021066 · Cited by 572
Schmidt, E. W., Nelson, J. T., Rasko, D. A., Sudek, S., Eisen, J. A., Haygood, M. G., & Ravel, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501424102 · Cited by 567
Natural products to drugs: natural product derived compounds in clinical trials
Butler, M. S. (2005) · Natural Product Reports · doi:10.1039/b402985m · Cited by 491
Plant-derived compounds in clinical trials
Saklani, A., & Kutty, S. K. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.10.010 · Cited by 477
Anticancer Activity of Natural Compounds from Plant and Marine Environment
Lichota, A., & Gwozdzinski, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113533 · Cited by 473
Terpenoids: Opportunities for Biosynthesis of Natural Product Drugs Using Engineered Microorganisms
Ajikumar, P. K., Tyo, K., Carlsen, S., Mucha, O., Phon, T. H., & Stephanopoulos, G. (2008) · Molecular Pharmaceutics · doi:10.1021/mp700151b · Cited by 447
Bioactive Secondary Metabolites from Plant Sources: Types, Synthesis, and Their Therapeutic Uses
Twaij, B. M., & Hasan, M. N. (2022) · International Journal of Plant Biology · doi:10.3390/ijpb13010003 · Cited by 441
Blunt, J. W., Copp, B. R., Munro, M. H. G., Northcote, P. T., & Prinsep, M. R. (2006) · Natural Product Reports · doi:10.1039/b502792f · Cited by 418
Mehbub, M., Lei, J., Franco, C., & Zhang, W. (2014) · Marine Drugs · doi:10.3390/md12084539 · Cited by 417
Charting, Navigating, and Populating Natural Product Chemical Space for Drug Discovery
Lachance, H., Wetzel, S., Kumar, K., & Waldmann, H. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300288g · Cited by 398
Marine Peptides: Bioactivities and Applications
Cheung, R., Ng, T., & Wong, J. (2015) · Marine Drugs · doi:10.3390/md13074006 · Cited by 391
Bioactive Compounds from Marine Bacteria and Fungi
Debbab, A., Aly, A. H., Lin, W. H., & Proksch, P. (2010) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2010.00179.x · Cited by 364
Natural Products from Marine Organisms and Their Associated Microbes
König, G. M., Kehraus, S., Seibert, S. F., Abdel‐Lateff, A., & Müller, D. (2006) · ChemBioChem · doi:10.1002/cbic.200500087 · Cited by 318
Natural Products as a Foundation for Drug Discovery
Beutler, J. A. (2009) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph0911s46 · Cited by 296
Rocha, J., Peixe, L., Gomes, N. C. M., & Calado, R. (2011) · Marine Drugs · doi:10.3390/md9101860 · Cited by 274
Imidazole, oxazole and thiazole alkaloids
Jin, Z. (2006) · Natural Product Reports · doi:10.1039/b502166a · Cited by 270
Prospective of the cosmeceuticals derived from marine organisms
Kim, S.-K., Ravichandran, Y. D., Khan, S. B., & Kim, Y. T. (2008) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-008-0113-5 · Cited by 267
Oceans and human health: Emerging public health risks in the marine environment
Fleming, L. E., Broad, K., Clement, A., Dewailly, E., Elmir, S., Knap, A., Pomponi, S. A., Smith, S., Solo Gabriele, H., & Walsh, P. (2006) · Marine Pollution Bulletin · doi:10.1016/j.marpolbul.2006.08.012 · Cited by 260
Antiviral Lead Compounds from Marine Sponges
Sagar, S., Kaur, M., & Minneman, K. P. (2010) · Marine Drugs · doi:10.3390/md8102619 · Cited by 259
The Impact of Bacterial Genomics on Natural Product Research
Bode, H. B., & Müller, R. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200501080 · Cited by 253
Potential of sponges and microalgae for marine biotechnology
Wijffels, R. H. (2008) · Trends in biotechnology · doi:10.1016/j.tibtech.2007.10.002 · Cited by 201
Datta, A., Deng, S., Gopal, V., Yap, K. C.-H., Halim, C. E., Lye, M. L., Ong, M. S., Tan, T. Z., Sethi, G., Hooi, S. C., et al. (2021) · Cancers · doi:10.3390/cancers13081882 · Cited by 184
Marine-Derived Compounds with Potential Use as Cosmeceuticals and Nutricosmetics
Alves, A., Sousa, E., Kijjoa, A., & Pinto, M. (2020) · Molecules · doi:10.3390/molecules25112536 · Cited by 169
New drugs from marine microbes: The tide is turning
Newman, D. J., & Hill, R. T. (2006) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-006-0115-2 · Cited by 144
Self-citationOftedal, L., Selheim, F., Wahlsten, M., Sivonen, K., Døskeland, S. O., & Herfindal, L. (2010) · Marine Drugs · doi:10.3390/md8102659 · Cited by 62
Bose, U., Hewavitharana, A., Ng, Y., Shaw, P., Fuerst, J., & Hodson, M. (2015) · Marine Drugs · doi:10.3390/md13010249 · Cited by 64
Induction of apoptosis in cancer cell lines by the Red Sea brine pool bacterial extracts
Sagar, S., Esau, L., Holtermann, K., Hikmawan, T., Zhang, G., Stingl, U., Bajic, V. B., & Kaur, M. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-344 · Cited by 41
Bioactive compounds from marine yeast inhibits lung cancer
Sekar, M., Poomalai, S., Gunasekaran, M., Mani, P., & Krishnamurthy, A. (2015) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2015.58.s2 · Cited by 8
Metadata
- Authors
- Newman, D. J., & Cragg, G. M.
- Venue
- Journal of Natural Products
- Publisher
- American Chemical Society (ACS)
- Published
- 2004-06-11
- Volume
- 67
- Issue
- 8
- Pages
- 1216-1238
- ISSN
- 0163-3864 (ISSN-L)
- 1520-6025
- OpenAlex
- W2052767109
- Cited by
- 759
- References
- 115
- FWCI
- 25.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.